ITI Pharma and Healthcare Fund Regular vs UTI Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹1097 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 28% |
| Expense Ratio | 2.35 | 2.22 |
| Manager | Rohan Korde | Kamal Gada |
| ISIN Code | INF00XX01BL5 | INF789F01695 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | 1.47% | -0.28% |
| 6 Month | 2.84% | 7.05% |
| 1 Year | 1.13% | 5.58% |
| 3 Year | 20.62% | 24.83% |
| 5 Year | - | 17.83% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | 1.03% | 1.66% |
| 1 Year | 4.35% | 10.03% |
| 3 Year | 18.67% | 23.72% |
| 5 Year | - | 19.65% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 18.94% | 11.94% |
| 3 Year | 20.21% | 16.4% |
| 5 Year | - | 14.62% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 15.65% | 15.78% |
| Sharp | 0.78% | 1.02% |
| Beta | 0.95% | 0.95% |
| Alpha | -2.36% | 1.53% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Rohan Korde | Kamal Gada |
| Total AUM | ₹4626 Cr | ₹870 Cr |
| Funds Managed | 10 | 1 |
| ITI Pharma and Healthcare Fund Regular - Growth | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 3.56 | 4.01 |
| Large Cap | 29.45 | 22.4 |
| Mid Cap | 37.33 | 33.54 |
| Small Cap | 29.66 | 40.04 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.52 | 1.02 |
| Healthcare | 91.78 | 97.9 |
| Basic Materials | 3.67 | 1.07 |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | - |
Top Comparisons
Mahindra Manulife Large & Mid Cap Fund - Regular Plan - Growth
3Y Returns17.05%
Motilal Oswal Large and Midcap Fund - Regular Plan Growth
3Y Returns28.32%
ICICI Prudential Exports & Services Fund - Growth
3Y Returns20.75%
Quant ESG Integration Strategy Fund Regular - Growth
3Y Returns15.58%
WhiteOak Capital Special Opportunities Fund-Reg (G)
3Y Returns0%
AXIS Nifty Bank Index Fund - Regular (G)
3Y Returns0%
Aditya Birla Sun Life Corporate Bond Fund - Growth - Regular Plan
3Y Returns7.97%
Canara Robeco CorpoRate Bond Fund - Regular Plan - Growth Option
3Y Returns6.84%